Pediatric Rheumatologist|Vasculitis Research Fellow @SickKids|Offspring of @canna_lab and @ChildrensPgh| PhD candidate @DrRaeYeung @UofTIMS #rheumtwitter
Hey @Penn_IFI @PennBiology@IGGPenn! We're looking for a new tech for this summer to (try to) fill @DangitVinh's enormous shoes😭. Promising Penn senior could get a jumpstart by joining now. We study inflammation, especially IL-18 but lesser cytokines too. DM or email!
New @CDCMMWR on Multisystem Inflammatory Syndrome (MIS-C), due to COVID, in children, ages 12-18.
*Pfizer's vaccine was 91% effective against MIS-C
*Among critically ill MIS-C patients requiring life support, all were unvaccinated.
https://t.co/6seJs6kN9R
New Research: Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum: Kawasaki disease (KD) and systemic juvenile idiopathic arthritis (sJIA) are two distinct systemic inflammatory diseases of childhood.… https://t.co/boCLtR6vAd #Pediatrics
1/ People say #MISC is not #KawasakiDisease. Okay. But what if Kawasaki disease took an s, one per virus, and MIS-C were one of many Kawasaki diseases & if MIS-C were a consequence of inborn errors of immunity (IEI) to SARS-CoV-2, different from those underlying C-19 pneumonia?
Hey #CIS2021, if you love IL-18 and cytotoxicity as much as we do, you needn't wait until Thursday to see our own Emily Landy's talk. https://t.co/FEmpSuUI1y CISAM21
New Research: VISTA: A Target to Manage the Innate Cytokine Storm: In recent years, the success of immunotherapy targeting immunoregulatory receptors (immune checkpoints) in cancer have generated enthusiastic support to target these receptors… https://t.co/XiDWdPpHko #immunology
We will be live @CHOP_Research/@Penn_IFI on 4/1 & hope to recruit a post-doc who will thrive in a spectacular translational immunology environment studying #IL18, #autoinflammation, #HLH, #MAS. Experience w CRISPR screens, live-cell 🔬 a +. DM or email if interested. Kindly RT.